KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 19 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $167,708 | -6.3% | 221,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $179,000 | +9.8% | 221,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $163,000 | -12.8% | 221,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $187,000 | +146.1% | 221,000 | +137.6% | 0.00% | +100.0% |
| Q4 2021 | $76,000 | +8.6% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $70,000 | -24.7% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $93,000 | -3.1% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $96,000 | -17.9% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $117,000 | +5.4% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $111,000 | -14.6% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $130,000 | -2.3% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | 0.0% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $133,000 | – | 93,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |